Insider Transactions in Q4 2022 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Laura Damme VP, Clinical Affairs |
SELL
Open market or private sale
|
Direct |
4,990
-100.0%
|
$294,410
$59.49 P/Share
|
|
Dec 15
2022
|
Laura Damme VP, Clinical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
4,990
+50.0%
|
$189,620
$38.46 P/Share
|
|
Dec 14
2022
|
Laura Damme VP, Clinical Affairs |
SELL
Open market or private sale
|
Direct |
5,947
-100.0%
|
$368,714
$62.43 P/Share
|
|
Dec 14
2022
|
Laura Damme VP, Clinical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,947
+50.0%
|
$225,986
$38.46 P/Share
|
|
Dec 13
2022
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
4,315
-11.75%
|
$267,530
$62.62 P/Share
|
|
Dec 13
2022
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,918
+23.31%
|
$224,884
$38.46 P/Share
|
|
Dec 09
2022
|
Miriam Provost VP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
3,613
-11.52%
|
$213,167
$59.0 P/Share
|
|
Dec 09
2022
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
5,126
+13.71%
|
$138,402
$27.3 P/Share
|
|
Dec 05
2022
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
36
+0.26%
|
$0
$0.28 P/Share
|
|
Dec 02
2022
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
10,000
-42.0%
|
$630,000
$63.5 P/Share
|
|
Dec 02
2022
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
23,037
+36.56%
|
$299,481
$13.01 P/Share
|
|
Dec 01
2022
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,051
+50.0%
|
$22,102
$2.21 P/Share
|
|
Dec 01
2022
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.99%
|
$610,000
$61.73 P/Share
|
|
Dec 01
2022
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.89%
|
$160,000
$16.14 P/Share
|
|
Dec 01
2022
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
3,000
-37.63%
|
$183,000
$61.66 P/Share
|
|
Dec 01
2022
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+44.31%
|
$0
$0.28 P/Share
|
|
Nov 23
2022
|
Stephanie Lovell |
SELL
Open market or private sale
|
Direct |
5,657
-100.0%
|
$333,763
$59.5 P/Share
|
|
Nov 23
2022
|
Stephanie Lovell |
BUY
Exercise of conversion of derivative security
|
Direct |
5,657
+50.0%
|
$265,879
$47.82 P/Share
|
|
Nov 22
2022
|
Stephanie Lovell |
SELL
Open market or private sale
|
Direct |
4,900
-100.0%
|
$284,200
$58.01 P/Share
|
|
Nov 22
2022
|
Stephanie Lovell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,900
+50.0%
|
$181,300
$37.04 P/Share
|
|
Nov 15
2022
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
14,483
-3.29%
|
$868,980
$60.13 P/Share
|
|
Nov 15
2022
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,254
-76.59%
|
$255,240
$60.06 P/Share
|
|
Nov 15
2022
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,254
+43.37%
|
$8,508
$2.21 P/Share
|
|
Nov 11
2022
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
2,748
-0.62%
|
$164,880
$60.03 P/Share
|
|
Nov 11
2022
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,702
-67.52%
|
$162,120
$60.03 P/Share
|
|
Nov 11
2022
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,702
+40.3%
|
$5,404
$2.21 P/Share
|
|
Nov 10
2022
|
David Weill |
SELL
Open market or private sale
|
Direct |
21,645
-61.59%
|
$1,212,120
$56.0 P/Share
|
|
Nov 10
2022
|
David Weill |
BUY
Exercise of conversion of derivative security
|
Direct |
21,645
+38.11%
|
$346,320
$16.0 P/Share
|
|
Nov 07
2022
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
2,769
-0.62%
|
$166,140
$60.07 P/Share
|
|
Nov 07
2022
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.64%
|
$560,000
$56.72 P/Share
|
|
Nov 07
2022
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.63%
|
$90,000
$9.18 P/Share
|
|
Nov 07
2022
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,044
-70.07%
|
$182,640
$60.04 P/Share
|
|
Nov 07
2022
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,044
+41.2%
|
$6,088
$2.21 P/Share
|
|
Nov 01
2022
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
3,000
-54.29%
|
$147,000
$49.22 P/Share
|
|
Nov 01
2022
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+44.31%
|
$0
$0.28 P/Share
|
|
Oct 03
2022
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.64%
|
$410,000
$41.74 P/Share
|
|
Oct 03
2022
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.89%
|
$20,000
$2.21 P/Share
|
|
Oct 03
2022
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
3,000
-54.19%
|
$126,000
$42.28 P/Share
|
|
Oct 03
2022
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+35.27%
|
$3,000
$1.25 P/Share
|